Intuit Inc Expands Enterprise Suite to Target MidMarket Business Growth Market Pricing Signals No Fed Rate Cut Before 2027 After Hot Inflation Data Retail Hiring Surge in April Contrasts with Cautious Consumer Signals David Miliband Warns of Separate Bedrooms for USEurope Ties Potential Market Uncertainty Diversified Energy Expands Permian Basin Presence With Maverick Natural Resources Acquisition Dekiln Partners with Johnson Tiles for Pilot Production of KilnFree Recycled Tiles SEED Q4 2011 Earnings EPS Surges 117 Above Estimates Strong Operational Execution MNRO Q1 2026 Earnings EPS Surpasses Estimates as Cost Management Drives Profitability BRN Q4 2024 Earnings Net Loss of 019 per Share Stock Declines 324 DXC Q1 2026 Earnings EPS Beats Estimates Despite Slight Stock Decline EVGO Q1 2026 Earnings Narrower Loss Surpasses Analyst Expectations Amidst Operational Gains XNCR Q1 2026 Earnings Significant EPS Miss Despite Positive Stock Movement Voya Emerging Markets High Income Dividend Equity Fund IHD Edges Higher as Investors Seek Yield Nuveen Dynamic Municipal Opportunities Fund NDMO Holds Steady Near 1030 as RangeBound Trading Persists Ultragenyx RARE Dips 135 as Stock Tests Key Support Zone Near 2222 Olema Pharmaceuticals OLMA Tests Key Support Amid Broad Market Pressure WEC Energy Group Stock Holds Steady Near 113 as Utility Sector Maintains Stability AI Infrastructure Stocks Plunge as Chinas DeepSeek Triggers Broad Market Rout WAB Q1 2026 Earnings Strong EPS Beat Drives Modest Stock Gain UMBFO Preferred Shares Edge Higher Amid Steady Demand in Financial Preferreds ING Q1 2026 Earnings EPS Beats Estimates Stock Rises 22 Nakamoto Inc NAKA Q4 2025 Earnings EPS Misses Estimates Stock Rises Amid Uncertainty NPCE Q1 2026 Earnings Narrower Loss Beats Estimates Stock Gains GameStop GME Q1 2026 Earnings EPS Surges Past Estimates on Cost Discipline Revenue Remains Undisclosed CVKD Q1 2026 Earnings Narrower Loss Surprises Clinical Progress Maintained ARDX Q1 2026 Earnings EPS Misses Estimates by 142 Revenue Not Disclosed Ionis Pharmaceuticals Q1 2026 Earnings EPS Beat Driven by Cost Discipline Stock Holds Steady